Literature DB >> 238820

The distribution and excretion of 2,4,5,2',5'-pentachlorobiphenyl in the rat.

H B Matthews, M W Anderson.   

Abstract

Rats received single intravenous doses (0.6 or 6.0 mg/kg) of 2,4,5,2',5'-pentachlorobiphenyl-14C (5-CB). The distribution and ecretion of 5-CB-derived material were investigated at periods ranging from 10 min to 42 days after administration and found to be first-order rate processes in the dose range studied. Blood, liver, muscle, skin, and adipose tissues were found to be the most important tissues to the distribution of this compound. More than 90% of the total dose was removed from the blood within 10 min after administration. Most of the radioactivity was initially deposited in the liver and muscle, and then translocated to the skin and adipose tissue. The decay rate of radioactivity from each of the tissues could be described by the sum of two or more exponentials. Metabolism to more polar compounds appears to be a prerequisite to excretion, and most of the radioactivity was excreted in the bile and ultimately in the feces. Excretion in the urine accounted for less than 7% of the total dose and ceased at approximately 8 or 9 days after 5-CB-administration. Studies of the distribution and excretion of 5-CB-derived material over extended periods of time, 1-42 days, demonstrated the importance of the adipose tissue and skin as long-term storage sites, and demonstrated that the decay rate of 5-CB from the tissues paralleled the decreasing rate of excretion in the feces.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 238820

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  19 in total

1.  Prenatal PCBs disrupt early neuroendocrine development of the rat hypothalamus.

Authors:  Sarah M Dickerson; Stephanie L Cunningham; Andrea C Gore
Journal:  Toxicol Appl Pharmacol       Date:  2011-01-26       Impact factor: 4.219

2.  Comparative toxicokinetics of 2,2'- and 4,4'-dichlorobiphenyls in the pond snail Lymnaea stagnalis (L.).

Authors:  M Wilbrink; M Treskes; T A De Vlieger; N P Vermeulen
Journal:  Arch Environ Contam Toxicol       Date:  1990 Jul-Aug       Impact factor: 2.804

3.  In vivo binding of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(1,3-dichloro-2-propyl) phosphate to macromolecules of mouse liver, kidney and muscle.

Authors:  N M Morales; H B Matthews
Journal:  Bull Environ Contam Toxicol       Date:  1980-07       Impact factor: 2.151

4.  Predictors of plasma polychlorinated biphenyl concentrations among reproductive-aged black women.

Authors:  Amelia K Wesselink; Traci N Bethea; Michael McClean; Jennifer Weuve; Paige L Williams; Russ Hauser; Andreas Sjödin; Theodore M Brasky; Donna D Baird; Lauren A Wise
Journal:  Int J Hyg Environ Health       Date:  2019-07-05       Impact factor: 5.840

5.  Endocrine disruption of brain sexual differentiation by developmental PCB exposure.

Authors:  Sarah M Dickerson; Stephanie L Cunningham; Heather B Patisaul; Michael J Woller; Andrea C Gore
Journal:  Endocrinology       Date:  2010-12-29       Impact factor: 4.736

6.  Elimination half-lives of polychlorinated biphenyl congeners in children.

Authors:  Philippe Grandjean; Esben Budtz-Jørgensen; Dana B Barr; Larry L Needham; Pal Weihe; Birger Heinzow
Journal:  Environ Sci Technol       Date:  2008-09-15       Impact factor: 9.028

Review 7.  Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

Authors:  Isaac N Pessah; Gennady Cherednichenko; Pamela J Lein
Journal:  Pharmacol Ther       Date:  2009-11-25       Impact factor: 12.310

8.  Enteric transport of chlordecone (Kepone) in the rat.

Authors:  P M Bungay; R L Dedrick; H B Matthews
Journal:  J Pharmacokinet Biopharm       Date:  1981-06

9.  Disposition and excretion of 2-chlorodibenzofuran in the rat.

Authors:  C Tohyama; S Hirano; K T Suzuki
Journal:  Arch Environ Contam Toxicol       Date:  1992-02       Impact factor: 2.804

10.  Biological disposition of intravenously administered 131I-labeled anti-EGF-receptor antibody (RG 83852) in the rat.

Authors:  V K Khetarpal; L S Storbeck
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.